Results
cough
ADVERSE EVENTS
Inhaled EB was well tolerated by participants, with no adverse events reported. In total, cough was elicited among 42 out of 60 enrolled participants (70%) in response to at least one of the selected concentrations of 20%–60% v/v EB. Therefore, 